CD9 and breast cancer: P15. Co-overexpression of Tumour Necrosis Factor Alpha (TNFa), Junctional Adhesion Molecule-A (JAM-A) alpha(v)beta(3) integrin, RhoA and CD9 is associated with worse prognosis in breast cancer patients.